MOL UROL 润色咨询

molecular urology

出版年份:暂无数据 年文章数:0 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=0b0a5030, cover=null, fullname=molecular urology, abbr=MOL UROL, pyear=暂无数据, frequence=null, articleNumbers=0, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据), issn=1091-5362, greenSci=https://www.greensci.net/search?kw=1091-5362, scijournal=https://www.scijournal.org/impact-factor-of-MOL-UROL.shtml, medsciHotlightString=null, medsciHotlightRealtime=0.452, medsciHotlight=0.475, medsciHotlight5year=0.917528, citescore=0.0, hIndex=0, impactFactor=null, orgnization=Mary Ann Liebert Inc., orgnizationUrl=http://www.liebertpub.com, country=United States, countryCn=美国, isOa=null, isOaString=不清楚, sciScie=null, bigclassCas=null, smallclassCas=, website=http://www.liebertonline.com/mou, websiteHits=2278, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=, submitWebsiteHits=1, content=Published by Mary Ann Liebert. ISSN: 1091-5362.<br /><br />This publication has been discontinued. This translational, state-of-the-art journal covers basic and clinical research on subjects related to the management of patients with urologic diseases, with a particluar emphasis on new diagnostics and treatments using molecular-level technologies. Topics covered include: oncology, urolithiasis, incontinence, impotence, kidney transplant and renal disorders. Indexed in Index Medicus, MEDLINE, Current Contents/Clinical Medicine, EMBASE, Excerpta Medicia, Research Alert, SciSearch/Science Citation Index - Expanded., totalCites=null, brief=MOL UROL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=泌尿学与肾脏学" >泌尿学与肾脏学</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=0b0a5030'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2012, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2013, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2014, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2019, medsciHotlight=1.753), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.366), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.436), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.504), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=0.452)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1091-5362[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=molecular urology[ta], article_number=0, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MOL UROL/molecular urology
ISSN
1091-5362
影响指数话题
预警等级
MedSci期刊指数
0.452 (MedSci实时期刊指数) | 0.917528 (5年期刊指数)
CiteScore值
0.0
h-index
0
h5-median
暂无数据
出版社/管理机构
杂志由 Mary Ann Liebert Inc. 出版或管理
出版国家/地区
United States 美国
出版周期
暂无数据
出版年份
暂无数据
是否OA
不清楚
被收录情况
暂无数据
JCR分区
暂无数据
中科院分区
大类:
小类: